The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

Background and Aim Tacrolimus (TAC) is an important therapeutic option for remission induction in patients with refractory ulcerative colitis (UC). However, there is little evidence available on long‐term outcomes and maintenance treatments after TAC therapy, especially in cases with previous tumor...

Full description

Bibliographic Details
Main Authors: Taketo Suzuki, Tsutomu Mizoshita, Satoshi Tanida, Naomi Sugimura, Takahito Katano, Hirotada Nishie, Hiromi Kataoka
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:JGH Open
Subjects:
long‐term outcomes
maintenance treatments
tacrolimus
tumor necrosis factor‐α inhibitor therapy
ulcerative colitis
Online Access:https://doi.org/10.1002/jgh3.12140

Internet

https://doi.org/10.1002/jgh3.12140

Similar Items